Trials / Recruiting
RecruitingNCT06842303
Contribution of New Pancreatic MRI Sequences for the Evaluation of Tumor Response in Pancreatic Adenocarcinomas
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- Sponsor
- Central Hospital, Nancy, France · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Pancreatic adenocarcinoma is the most pessimistic digestive cancer in terms of prognosis. Tumor response assessment is crucial, and the recent development of new magnetic resonance imaging sequences, such as high resolution applied to diffusion sequences (Harder et al., 2022) or magnetic resonance elastography (MRE) (Steinkohl et al., 2021), could help address this issue.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Magnetic resonance elastography (MRE). | Magnetic resonance elastography (MRE) is an imaging technique that measures tissue stiffness by assessing the deformation waves produced under external pressure |
| DEVICE | High-resolution diffusion sequence in MRI | High-resolution diffusion sequence in MRI is an imaging technique that uses the movement of water molecules within tissues to generate detailed images. |
Timeline
- Start date
- 2025-06-06
- Primary completion
- 2027-06-06
- Completion
- 2027-06-06
- First posted
- 2025-02-24
- Last updated
- 2025-07-17
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT06842303. Inclusion in this directory is not an endorsement.